Web Results

Cipher Pharmaceuticals

www.cipherpharma.com/

Cipher Pharmaceuticals is a growing specialty company with a focus on dermatology. Our goal is to develop and acquire best-in-class skin care solutions.

Innocutis Medical, LLC: Private Company Information - Businessweek

www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=131237955

Innocutis Medical, LLC company research & investing information. ... United States by its commercial partner, Innocutis Holdings, and the granting of a new U.S. ...

Charleston drug company sold for $45.5M to Canada's Cipher ...

www.postandcourier.com/article/20150416/PC05/150419505/1177/charleston-drug-company-sold-for-455m-to-canada-x2019-s-cipher-pharmaceuticals

Apr 16, 2015 ... Among other dermatological remedies, Innocutis markets the ... said it acquired privately held Innocutis Holdings LLC for $45.5 million in cash ...

Innocutis Holdings LLC - Company Profile - BioCentury

www.biocentury.com/companies/innocutis_holdings_llc

Apr 2, 2012 ... Innocutis' detailed financings; Comprehensive pipeline breakdown, including molecular targets & partnerships. 17 years of in-depth BioPharma ...

Charles F. Jenkins | LinkedIn

www.linkedin.com/in/charles-f-jenkins-b1043732

Cipher Pharmaceuticals Inc. Previous. Innocutis Holdings, LLC,; Innocutis Medical, LLC,; Medicis. Education. University of South Carolina-Columbia. Websites.

DailyMed - UMECTA UREA- urea film

dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd7b3fe5-8ba6-4808-8ead-1b20a87a2ed2

NDC Code(s): 68712-010-01, 68712-010-03, 68712-010-04; Packager: Innocutis Holdings LLC. Category: HUMAN PRESCRIPTION DRUG LABEL; DEA ...

DailyMed - UMECTA PD UREA- urea emulsion

dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ce953fdf-a73a-4f7e-8946-959346990626

More Info For This Drug. View Label Archives; RxNorm; Get Label RSS Feed. NDC Code(s): 68712-017-01, 68712-017-02; Packager: Innocutis Holdings LLC.

DailyMed - UMECTA MOUSSE UREA - urea aerosol, foam

dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=53f903a2-2b5c-4584-8e91-2c9f41b883ea

NDC Code(s): 68712-020-01; Packager: Innocutis Holdings LLC. Category: HUMAN PRESCRIPTION DRUG LABEL; DEA Schedule: None; Marketing Status:  ...

Cipher Pharmaceuticals enters US market with Innocutis acquisition

www.centerwatch.com/news-online/2015/04/13/cipher-pharmaceuticals-enters-us-market-with-innocutis-acquisition/

Apr 13, 2015 ... Cipher Pharmaceuticals, a Canada-based specialty pharmaceutical dermatology company, has acquired Innocutis Holdings, a Charleston, ...

Cipher Pharma maps out its path to success - The Globe and Mail

www.theglobeandmail.com/globe-investor/investment-ideas/cipher-pharma-maps-out-its-path-to-success/article24053442/

Apr 21, 2015 ... ... company Innocutis Holdings LLC for $45.5-million (U.S.) in cash, its ... Innocutis gives Cipher critical infrastructure to sell its products in the ...

More Info

Cipher Pharmaceuticals announces U.S. commercial entry through ...

www.prnewswire.com

Apr 13, 2015 ... ... that it has acquired INNOCUTIS Holdings LLC ("INNOCUTIS"), a privately held specialty dermatology company, for US$45.5 million in cash.

Cipher Pharmaceuticals acquires INNOCUTIS Holdings ... - Onxeo

www.onxeo.com

Apr 13, 2015 ... oncology drugs, today announced Cipher Pharmaceuticals' (NASDAQ: CPHR) acquisition of INNOCUTIS. Holdings LLC, the licensee of ...

innocutis | CrunchBase

www.crunchbase.com

Innocutis is a pharmaceutical and medical device company developing ... Founded: 2005; Aliases: Innocutis Holdings, LLC; Employees: 1 in CrunchBase.